T1	B-Protein	0	11	Granulocyte	Granulocyte	B-NP	NN	B-protein	5	NMOD	B-protein
T1	I-Protein	12	18	colony	colony	I-NP	NN	I-protein	5	NMOD	I-protein
T1	I-Protein	18	19	-	-	O	HYPH	I-protein	5	NMOD	I-protein
T1	I-Protein	19	30	stimulating	stimulate	B-VP	VBG	I-protein	5	NMOD	I-protein
T1	I-Protein	31	37	factor	factor	B-NP	NN	I-protein	6	SUB	I-protein
O	O	38	47	activates	activate	B-VP	VBZ	O	0	ROOT	O
O	O	48	49	a	a	B-NP	DT	O	11	NMOD	O
O	O	50	52	72	72	I-NP	CD	B-protein	11	NMOD	B-protein
O	O	52	53	-	-	I-NP	HYPH	I-protein	11	NMOD	I-protein
O	O	53	56	kDa	kDa	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	57	64	isoform	isoform	I-NP	NN	I-protein	6	OBJ	I-protein
O	O	65	67	of	of	B-PP	IN	O	11	NMOD	O
T2	B-Protein	68	73	STAT3	STAT3	B-NP	NN	B-protein	12	PMOD	B-protein
O	O	74	76	in	in	B-PP	IN	O	11	NMOD	O
O	O	77	82	human	human	B-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	83	94	neutrophils	neutrophil	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	94	95	.	.	O	.	O	6	P	O

T3	B-Protein	97	108	Granulocyte	Granulocyte	B-NP	NN	B-protein	5	NMOD	B-protein
T3	I-Protein	109	115	colony	colony	I-NP	NN	I-protein	5	NMOD	I-protein
T3	I-Protein	115	116	-	-	O	HYPH	I-protein	5	NMOD	I-protein
T3	I-Protein	116	127	stimulating	stimulate	B-VP	VBG	I-protein	5	NMOD	I-protein
T3	I-Protein	128	134	factor	factor	B-NP	NN	I-protein	11	NMOD	I-protein
O	O	135	136	(	(	O	(	O	10	DEP	O
T4	B-Protein	136	137	G	G	B-NP	NN	O	9	NMOD	O
T4	I-Protein	137	138	-	-	B-NP	HYPH	O	9	P	O
T4	I-Protein	138	141	CSF	CSF	I-NP	NN	B-protein	10	DEP	B-protein
O	O	141	142	)	)	O	)	O	5	NMOD	O
O	O	143	152	signaling	signaling	B-NP	NN	O	12	SUB	O
O	O	153	161	involves	involve	B-VP	VBZ	O	0	ROOT	O
O	O	162	172	activation	activation	B-NP	NN	O	12	OBJ	O
O	O	173	175	of	of	B-PP	IN	O	13	NMOD	O
O	O	176	181	STATs	STAT	B-NP	NNS	B-protein	17	NMOD	B-protein
O	O	181	182	,	,	O	,	O	17	P	O
O	O	183	191	proteins	protein	B-NP	NNS	O	14	PMOD	O
O	O	192	196	that	that	B-NP	WDT	O	17	NMOD	O
O	O	197	202	serve	serve	B-VP	VBP	O	18	SBAR	O
O	O	203	206	the	the	B-NP	DT	O	22	NMOD	O
O	O	207	211	dual	dual	I-NP	JJ	O	22	NMOD	O
O	O	212	220	function	function	I-NP	NN	O	27	NMOD	O
O	O	221	223	of	of	B-PP	IN	O	22	NMOD	O
O	O	224	230	signal	signal	B-NP	NN	O	25	NMOD	O
O	O	231	243	transduction	transduction	I-NP	NN	O	23	PMOD	O
O	O	244	247	and	and	O	CC	O	27	NMOD	O
O	O	248	258	activation	activation	B-NP	NN	O	19	OBJ	O
O	O	259	261	of	of	B-PP	IN	O	27	NMOD	O
O	O	262	275	transcription	transcription	B-NP	NN	O	28	PMOD	O
O	O	275	276	.	.	O	.	O	12	P	O

O	O	277	279	We	We	B-NP	PRP	O	3	SUB	O
O	O	280	290	previously	previously	B-ADVP	RB	O	3	VMOD	O
O	O	291	303	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	304	308	that	that	B-SBAR	IN	O	3	VMOD	O
T5	B-Protein	309	310	G	G	B-NP	NN	O	7	NMOD	O
T5	I-Protein	310	311	-	-	B-NP	HYPH	O	7	NMOD	O
T5	I-Protein	311	314	CSF	CSF	I-NP	NN	B-protein	8	SUB	B-protein
O	O	315	324	activated	activate	B-VP	VBD	O	4	SBAR	O
O	O	325	326	a	a	B-NP	DT	O	14	NMOD	O
O	O	327	335	distinct	distinct	I-NP	JJ	O	14	NMOD	O
T6	B-Protein	336	341	Stat3	Stat3	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	341	342	-	-	B-NP	HYPH	O	14	NMOD	O
O	O	342	346	like	like	I-NP	JJ	O	14	NMOD	O
O	O	347	354	protein	protein	I-NP	NN	O	8	OBJ	O
O	O	355	357	in	in	B-PP	IN	O	8	VMOD	O
O	O	358	366	immature	immature	B-NP	JJ	B-cell_type	21	NMOD	B-cell_type
O	O	367	370	and	and	I-NP	CC	I-cell_type	21	NMOD	I-cell_type
O	O	371	377	mature	mature	I-NP	JJ	I-cell_type	21	NMOD	I-cell_type
O	O	378	384	normal	normal	I-NP	JJ	I-cell_type	21	NMOD	I-cell_type
O	O	385	392	myeloid	myeloid	I-NP	JJ	I-cell_type	21	NMOD	I-cell_type
O	O	393	398	cells	cell	I-NP	NNS	I-cell_type	23	NMOD	I-cell_type
O	O	398	399	,	,	O	,	O	23	P	O
T7	B-Protein	400	405	StatG	StatG	B-NP	NN	B-protein	15	PMOD	B-protein
O	O	405	406	.	.	O	.	O	3	P	O

T8	B-Protein	407	412	StatG	StatG	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	413	415	in	in	B-PP	IN	O	1	NMOD	O
O	O	416	422	normal	normal	B-NP	JJ	B-cell_type	7	NMOD	B-cell_type
O	O	423	431	immature	immature	I-NP	JJ	I-cell_type	7	NMOD	I-cell_type
O	O	432	437	human	human	I-NP	JJ	I-cell_type	7	NMOD	I-cell_type
O	O	438	445	myeloid	myeloid	I-NP	JJ	I-cell_type	7	NMOD	I-cell_type
O	O	446	451	cells	cell	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	451	452	,	,	O	,	O	9	P	O
O	O	453	454	i	i	B-NP	NN	O	18	NMOD	O
O	O	454	455	.	.	O	.	O	9	P	O
O	O	455	456	e	e	B-NP	NN	O	18	NMOD	O
O	O	456	457	.	.	O	.	O	18	P	O
O	O	458	463	adult	adult	B-NP	JJ	B-cell_type	18	NMOD	B-cell_type
T9	B-Protein	464	468	CD34	CD34	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	468	469	+	+	B-NP	SYM	I-cell_type	18	NMOD	I-cell_type
O	O	470	474	bone	bone	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	475	481	marrow	marrow	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	482	487	cells	cell	I-NP	NNS	I-cell_type	20	SUB	I-cell_type
O	O	487	488	,	,	O	,	O	18	P	O
O	O	489	492	was	be	B-VP	VBD	O	0	ROOT	O
O	O	493	501	composed	compose	I-VP	VBN	O	20	VC	O
O	O	502	504	of	of	B-PP	IN	O	21	VMOD	O
T10	B-Protein	505	514	Stat3beta	Stat3beta	B-NP	NN	B-protein	22	PMOD	B-protein
O	O	514	515	.	.	O	.	O	20	P	O

O	O	516	520	This	This	B-NP	DT	O	2	NMOD	O
O	O	521	534	investigation	investigation	I-NP	NN	O	3	SUB	O
O	O	535	538	was	be	B-VP	VBD	O	0	ROOT	O
O	O	539	549	undertaken	undertake	I-VP	VBN	O	3	VC	O
O	O	550	552	to	to	B-VP	TO	O	6	VMOD	O
O	O	553	562	determine	determine	I-VP	VB	O	3	VMOD	O
O	O	563	566	the	the	B-NP	DT	O	8	NMOD	O
O	O	567	578	composition	composition	I-NP	NN	O	18	NMOD	O
O	O	579	581	of	of	B-PP	IN	O	8	NMOD	O
T11	B-Protein	582	587	StatG	StatG	B-NP	NN	B-protein	9	PMOD	B-protein
O	O	588	590	in	in	B-PP	IN	O	8	NMOD	O
O	O	591	597	mature	mature	B-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	598	604	normal	normal	I-NP	JJ	I-cell_type	16	NMOD	I-cell_type
O	O	605	610	human	human	I-NP	JJ	I-cell_type	16	NMOD	I-cell_type
O	O	611	618	myeloid	myeloid	I-NP	JJ	I-cell_type	16	NMOD	I-cell_type
O	O	619	624	cells	cell	I-NP	NNS	I-cell_type	11	PMOD	I-cell_type
O	O	624	625	,	,	O	,	O	18	P	O
O	O	626	627	i	i	B-NP	NN	O	6	OBJ	O
O	O	627	628	.	.	O	.	O	18	P	O
O	O	628	629	e	e	B-NP	NN	O	18	NMOD	O
O	O	629	630	.	.	O	.	O	24	P	O
O	O	631	648	polymorphonuclear	polymorphonuclear	B-NP	JJ	B-cell_type	24	NMOD	B-cell_type
O	O	649	661	neutrophilic	neutrophilic	I-NP	JJ	I-cell_type	24	NMOD	I-cell_type
O	O	662	674	granulocytes	granulocyte	I-NP	NNS	I-cell_type	18	NMOD	I-cell_type
O	O	675	676	(	(	O	(	O	27	DEP	O
O	O	676	679	PMN	PMN	B-NP	NN	B-cell_type	27	DEP	B-cell_type
O	O	679	680	)	)	O	)	O	24	NMOD	O
O	O	680	681	.	.	O	.	O	3	P	O

O	O	682	687	These	These	B-NP	DT	O	2	NMOD	O
O	O	688	695	studies	study	I-NP	NNS	O	3	SUB	O
O	O	696	704	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	705	709	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	710	713	the	the	B-NP	DT	O	7	NMOD	O
O	O	714	719	major	major	I-NP	JJ	B-protein	7	NMOD	B-protein
O	O	720	727	protein	protein	I-NP	NN	I-protein	4	SBAR	I-protein
O	O	728	730	in	in	B-PP	IN	O	7	NMOD	O
O	O	731	739	extracts	extract	B-NP	NNS	O	8	PMOD	O
O	O	740	742	of	of	B-PP	IN	O	9	NMOD	O
O	O	743	746	PMN	PMN	B-NP	NN	B-cell_type	10	PMOD	B-cell_type
O	O	747	756	activated	activate	B-VP	VBN	O	9	NMOD	O
O	O	757	759	by	by	B-PP	IN	O	12	VMOD	O
T12	B-Protein	760	761	G	G	B-NP	NN	B-protein	16	NMOD	B-protein
T12	I-Protein	761	762	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T12	I-Protein	762	765	CSF	CSF	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	766	768	to	to	B-VP	TO	O	18	VMOD	O
O	O	769	773	bind	bind	I-VP	VB	O	12	VMOD	O
O	O	774	777	the	the	B-NP	DT	O	30	SUB	O
T22	B-Entity	778	782	high	high	I-NP	JJ	O	30	VMOD	O
T22	I-Entity	782	783	-	-	I-NP	HYPH	O	30	P	O
T22	I-Entity	783	791	affinity	affinity	I-NP	NN	O	23	NMOD	O
T22	I-Entity	792	797	serum	serum	I-NP	NN	O	30	SUB	O
T22	I-Entity	797	798	-	-	O	HYPH	O	30	P	O
T22	I-Entity	798	807	inducible	inducible	B-NP	JJ	O	26	NMOD	O
T22	I-Entity	808	815	element	element	I-NP	NN	O	30	SUB	O
O	O	816	817	(	(	O	(	O	29	DEP	O
T23	B-Entity	817	821	hSIE	hSIE	B-NP	NN	B-DNA	29	DEP	B-DNA
O	O	821	822	)	)	O	)	O	26	NMOD	O
O	O	823	825	is	be	B-VP	VBZ	O	18	VMOD	O
O	O	826	827	a	a	B-NP	DT	O	35	NMOD	O
O	O	828	830	72	72	I-NP	CD	B-protein	35	NMOD	B-protein
O	O	830	831	-	-	I-NP	HYPH	I-protein	35	NMOD	I-protein
O	O	831	834	kDa	kDa	I-NP	NN	I-protein	35	NMOD	I-protein
O	O	835	842	protein	protein	I-NP	NN	I-protein	30	PRD	I-protein
O	O	843	847	that	that	B-NP	WDT	O	35	NMOD	O
O	O	848	853	cross	cross	B-NP	AFX	O	39	NMOD	O
O	O	853	854	-	-	I-NP	HYPH	O	39	NMOD	O
O	O	854	860	reacts	react	B-NP	NNS	O	36	SBAR	O
O	O	861	865	with	with	B-PP	IN	O	39	NMOD	O
T13	B-Protein	866	871	Stat3	Stat3	B-NP	NN	B-protein	43	NMOD	B-protein
O	O	872	882	monoclonal	monoclonal	I-NP	JJ	I-protein	43	NMOD	I-protein
O	O	883	891	antibody	antibody	I-NP	NN	I-protein	40	PMOD	I-protein
O	O	891	892	,	,	O	,	O	43	P	O
O	O	893	898	which	which	B-NP	WDT	O	43	NMOD	O
O	O	899	901	we	we	B-NP	PRP	O	47	SUB	O
O	O	902	906	have	have	B-VP	VBP	O	45	SBAR	O
O	O	907	917	designated	designate	I-VP	VBN	O	47	VC	O
T14	B-Protein	918	928	Stat3gamma	Stat3gamma	B-NP	NN	B-protein	48	VMOD	B-protein
O	O	928	929	.	.	O	.	O	3	P	O

T15	B-Protein	930	940	Stat3gamma	Stat3gamma	B-NP	NN	B-protein	2	SUB	B-protein
O	O	941	943	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	944	951	derived	derive	I-VP	VBN	O	2	VC	O
O	O	952	956	from	from	B-PP	IN	O	3	VMOD	O
T16	B-Protein	957	967	Stat3alpha	Stat3alpha	B-NP	NN	B-protein	4	PMOD	B-protein
O	O	968	970	by	by	B-PP	IN	O	3	VMOD	O
O	O	971	978	limited	limited	B-NP	JJ	O	8	NMOD	O
O	O	979	990	proteolysis	proteolysis	I-NP	NN	O	6	PMOD	O
O	O	991	994	and	and	O	CC	O	2	VMOD	O
O	O	995	1000	lacks	lack	B-VP	VBZ	O	2	VMOD	O
O	O	1001	1004	the	the	B-NP	DT	O	15	NMOD	O
T24	B-Entity	1005	1013	carboxyl	carboxyl	I-NP	NN	B-protein	15	NMOD	B-protein
T24	I-Entity	1013	1014	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T24	I-Entity	1014	1022	terminal	terminal	I-NP	JJ	I-protein	15	NMOD	I-protein
T24	I-Entity	1023	1030	portion	portion	I-NP	NN	I-protein	10	OBJ	I-protein
O	O	1031	1033	of	of	B-PP	IN	O	15	NMOD	O
T17	B-Protein	1034	1044	Stat3alpha	Stat3alpha	B-NP	NN	B-protein	16	PMOD	B-protein
O	O	1044	1045	.	.	O	.	O	2	P	O

O	O	1046	1053	Because	Because	B-SBAR	IN	O	14	VMOD	O
O	O	1054	1058	this	this	B-NP	DT	O	3	NMOD	O
O	O	1059	1065	region	region	I-NP	NN	O	6	SUB	O
O	O	1066	1068	of	of	B-PP	IN	O	3	NMOD	O
T18	B-Protein	1069	1079	Stat3alpha	Stat3alpha	B-NP	NN	B-protein	4	PMOD	B-protein
O	O	1080	1082	is	be	B-VP	VBZ	O	1	SBAR	O
O	O	1083	1091	involved	involve	I-VP	VBN	O	6	VC	O
O	O	1092	1094	in	in	B-PP	IN	O	7	VMOD	O
O	O	1095	1110	transcriptional	transcriptional	B-NP	JJ	O	10	NMOD	O
O	O	1111	1121	activation	activation	I-NP	NN	O	8	PMOD	O
O	O	1121	1122	,	,	O	,	O	14	P	O
O	O	1123	1126	our	our	B-NP	PRP$	O	13	NMOD	O
O	O	1127	1135	findings	finding	I-NP	NNS	O	14	SUB	O
O	O	1136	1143	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1144	1147	the	the	B-NP	DT	O	16	NMOD	O
O	O	1148	1159	possibility	possibility	I-NP	NN	O	14	OBJ	O
O	O	1160	1164	that	that	B-SBAR	IN	O	16	NMOD	O
T19	B-Protein	1165	1175	Stat3gamma	Stat3gamma	B-NP	NN	B-protein	19	SUB	B-protein
O	O	1176	1179	may	may	B-VP	MD	O	17	SBAR	O
O	O	1180	1182	be	be	I-VP	VB	O	19	VC	O
O	O	1183	1200	transcriptionally	transcriptionally	B-ADJP	RB	O	22	AMOD	O
O	O	1201	1209	inactive	inactive	I-ADJP	JJ	O	20	PRD	O
O	O	1210	1213	and	and	O	CC	O	24	DEP	O
O	O	1214	1217	may	may	B-VP	MD	O	17	SBAR	O
O	O	1218	1225	compete	compete	I-VP	VB	O	24	VC	O
O	O	1226	1230	with	with	B-PP	IN	O	25	VMOD	O
T20	B-Protein	1231	1241	Stat3alpha	Stat3alpha	B-NP	NN	B-protein	26	PMOD	B-protein
O	O	1242	1245	for	for	B-PP	IN	O	25	VMOD	O
T21	B-Protein	1246	1251	Stat3	Stat3	B-NP	NN	B-DNA	31	NMOD	B-DNA
T25	B-Entity	1252	1259	binding	binding	I-NP	NN	I-DNA	31	NMOD	I-DNA
T25	I-Entity	1260	1265	sites	site	I-NP	NNS	I-DNA	28	PMOD	I-DNA
O	O	1266	1268	in	in	B-PP	IN	O	31	NMOD	O
O	O	1269	1274	these	these	B-NP	DT	O	37	NMOD	O
O	O	1275	1285	terminally	terminally	I-NP	RB	B-cell_type	37	NMOD	B-cell_type
O	O	1286	1300	differentiated	differentiate	I-NP	VBN	I-cell_type	37	NMOD	I-cell_type
O	O	1301	1308	myeloid	myeloid	I-NP	JJ	I-cell_type	37	NMOD	I-cell_type
O	O	1309	1314	cells	cell	I-NP	NNS	I-cell_type	32	PMOD	I-cell_type
O	O	1314	1315	.	.	O	.	O	14	P	O
